CYC065 CDK Inhibitor and Venetoclax Study in Relapsed/Refractory AML or MDS
Clinical trial NCT04017546 · COMPLETED
Trial details
- NCT number
- NCT04017546
- Sponsor
- Cyclacel Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-08-02
- Primary completion
- 2022-11-15
- Enrollment
- 14
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.